Intermolecular (IMI) Getting Somewhat Positive Media Coverage, Analysis Finds

News headlines about Intermolecular (NASDAQ:IMI) have trended somewhat positive recently, according to Accern Sentiment. Accern rates the sentiment of press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Intermolecular earned a coverage optimism score of 0.23 on Accern’s scale. Accern also gave media stories about the semiconductor company an impact score of 45.4214756328251 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Shares of Intermolecular (NASDAQ:IMI) traded up $0.03 during midday trading on Friday, hitting $1.26. 17,081 shares of the stock were exchanged, compared to its average volume of 92,981. Intermolecular has a 1-year low of $0.80 and a 1-year high of $1.65.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this news story on another website, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The original version of this news story can be accessed at https://www.dispatchtribunal.com/2017/12/10/intermolecular-imi-getting-somewhat-positive-media-coverage-analysis-finds.html.

Intermolecular Company Profile

Intermolecular, Inc provides thin film solutions. The Company’s high productivity combinatorial (HPC) platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems.

Insider Buying and Selling by Quarter for Intermolecular (NASDAQ:IMI)

Receive News & Ratings for Intermolecular Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply